nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—lymphoid tissue—Creutzfeldt-Jakob disease	0.0736	0.111	CbGeAlD
Carfilzomib—PSMB10—central nervous system—Creutzfeldt-Jakob disease	0.0541	0.0814	CbGeAlD
Carfilzomib—PSMB10—cerebellum—Creutzfeldt-Jakob disease	0.0529	0.0796	CbGeAlD
Carfilzomib—PSMB10—brain—Creutzfeldt-Jakob disease	0.043	0.0646	CbGeAlD
Carfilzomib—PSMB5—spinal cord—Creutzfeldt-Jakob disease	0.038	0.0571	CbGeAlD
Carfilzomib—PSMB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.0366	0.0551	CbGeAlD
Carfilzomib—PSMB2—lymphoid tissue—Creutzfeldt-Jakob disease	0.0357	0.0537	CbGeAlD
Carfilzomib—PSMB1—spinal cord—Creutzfeldt-Jakob disease	0.0332	0.0499	CbGeAlD
Carfilzomib—PSMB2—spinal cord—Creutzfeldt-Jakob disease	0.0324	0.0487	CbGeAlD
Carfilzomib—PSMB5—cerebellum—Creutzfeldt-Jakob disease	0.0301	0.0453	CbGeAlD
Carfilzomib—PSMB8—brain—Creutzfeldt-Jakob disease	0.0277	0.0417	CbGeAlD
Carfilzomib—PSMB1—central nervous system—Creutzfeldt-Jakob disease	0.0269	0.0405	CbGeAlD
Carfilzomib—PSMB1—cerebellum—Creutzfeldt-Jakob disease	0.0263	0.0396	CbGeAlD
Carfilzomib—PSMB2—central nervous system—Creutzfeldt-Jakob disease	0.0263	0.0395	CbGeAlD
Carfilzomib—PSMB2—cerebellum—Creutzfeldt-Jakob disease	0.0257	0.0386	CbGeAlD
Carfilzomib—PSMB5—brain—Creutzfeldt-Jakob disease	0.0245	0.0368	CbGeAlD
Carfilzomib—PSMB1—brain—Creutzfeldt-Jakob disease	0.0214	0.0322	CbGeAlD
Carfilzomib—PSMB2—brain—Creutzfeldt-Jakob disease	0.0209	0.0314	CbGeAlD
Carfilzomib—ABCB1—blood plasma—Creutzfeldt-Jakob disease	0.014	0.0211	CbGeAlD
Carfilzomib—PSMB10—Regulation of mRNA stability by proteins that bind AU-rich elements—YWHAZ—Creutzfeldt-Jakob disease	0.0098	0.0292	CbGpPWpGaD
Carfilzomib—PSMB9—Regulation of mRNA stability by proteins that bind AU-rich elements—YWHAZ—Creutzfeldt-Jakob disease	0.00975	0.0291	CbGpPWpGaD
Carfilzomib—PSMB5—Regulation of mRNA stability by proteins that bind AU-rich elements—YWHAZ—Creutzfeldt-Jakob disease	0.00742	0.0222	CbGpPWpGaD
Carfilzomib—PSMB1—Regulation of mRNA stability by proteins that bind AU-rich elements—YWHAZ—Creutzfeldt-Jakob disease	0.00742	0.0222	CbGpPWpGaD
Carfilzomib—PSMB2—Regulation of mRNA stability by proteins that bind AU-rich elements—YWHAZ—Creutzfeldt-Jakob disease	0.00742	0.0222	CbGpPWpGaD
Carfilzomib—PSMB8—Regulation of mRNA stability by proteins that bind AU-rich elements—YWHAZ—Creutzfeldt-Jakob disease	0.00732	0.0218	CbGpPWpGaD
Carfilzomib—PSMB10—Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.00611	0.0182	CbGpPWpGaD
Carfilzomib—PSMB9—Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.00609	0.0182	CbGpPWpGaD
Carfilzomib—ABCB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00546	0.00821	CbGeAlD
Carfilzomib—ABCB1—spinal cord—Creutzfeldt-Jakob disease	0.00495	0.00744	CbGeAlD
Carfilzomib—PSMB8—Interferon Signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.0048	0.0143	CbGpPWpGaD
Carfilzomib—PSMB10—TCF dependent signaling in response to WNT—YWHAZ—Creutzfeldt-Jakob disease	0.00465	0.0139	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism of mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.00464	0.0138	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.00463	0.0138	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.00463	0.0138	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.00463	0.0138	CbGpPWpGaD
Carfilzomib—PSMB9—TCF dependent signaling in response to WNT—YWHAZ—Creutzfeldt-Jakob disease	0.00463	0.0138	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism of mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.00462	0.0138	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.00457	0.0136	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00456	0.0136	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00454	0.0136	CbGpPWpGaD
Carfilzomib—PSMB10—RNF mutants show enhanced WNT signaling and proliferation—YWHAZ—Creutzfeldt-Jakob disease	0.00451	0.0134	CbGpPWpGaD
Carfilzomib—PSMB9—RNF mutants show enhanced WNT signaling and proliferation—YWHAZ—Creutzfeldt-Jakob disease	0.00448	0.0134	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling by WNT in cancer—YWHAZ—Creutzfeldt-Jakob disease	0.00418	0.0125	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling by WNT in cancer—YWHAZ—Creutzfeldt-Jakob disease	0.00416	0.0124	CbGpPWpGaD
Carfilzomib—ABCB1—central nervous system—Creutzfeldt-Jakob disease	0.00402	0.00604	CbGeAlD
Carfilzomib—PSMB10—Metabolism of RNA—YWHAZ—Creutzfeldt-Jakob disease	0.00397	0.0118	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism of RNA—YWHAZ—Creutzfeldt-Jakob disease	0.00395	0.0118	CbGpPWpGaD
Carfilzomib—ABCB1—cerebellum—Creutzfeldt-Jakob disease	0.00392	0.0059	CbGeAlD
Carfilzomib—PSMB1—TCF dependent signaling in response to WNT—YWHAZ—Creutzfeldt-Jakob disease	0.00353	0.0105	CbGpPWpGaD
Carfilzomib—PSMB5—TCF dependent signaling in response to WNT—YWHAZ—Creutzfeldt-Jakob disease	0.00353	0.0105	CbGpPWpGaD
Carfilzomib—PSMB2—TCF dependent signaling in response to WNT—YWHAZ—Creutzfeldt-Jakob disease	0.00353	0.0105	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism of mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.00351	0.0105	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism of mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.00351	0.0105	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism of mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.00351	0.0105	CbGpPWpGaD
Carfilzomib—PSMB8—TCF dependent signaling in response to WNT—YWHAZ—Creutzfeldt-Jakob disease	0.00348	0.0104	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism of mRNA—YWHAZ—Creutzfeldt-Jakob disease	0.00346	0.0103	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00346	0.0103	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00346	0.0103	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00346	0.0103	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling by Wnt—YWHAZ—Creutzfeldt-Jakob disease	0.00345	0.0103	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling by Wnt—YWHAZ—Creutzfeldt-Jakob disease	0.00343	0.0102	CbGpPWpGaD
Carfilzomib—PSMB5—RNF mutants show enhanced WNT signaling and proliferation—YWHAZ—Creutzfeldt-Jakob disease	0.00341	0.0102	CbGpPWpGaD
Carfilzomib—PSMB1—RNF mutants show enhanced WNT signaling and proliferation—YWHAZ—Creutzfeldt-Jakob disease	0.00341	0.0102	CbGpPWpGaD
Carfilzomib—PSMB2—RNF mutants show enhanced WNT signaling and proliferation—YWHAZ—Creutzfeldt-Jakob disease	0.00341	0.0102	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00341	0.0102	CbGpPWpGaD
Carfilzomib—PSMB8—RNF mutants show enhanced WNT signaling and proliferation—YWHAZ—Creutzfeldt-Jakob disease	0.00337	0.01	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.00324	0.00968	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.00323	0.00963	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.00321	0.00957	CbGpPWpGaD
Carfilzomib—ABCB1—brain—Creutzfeldt-Jakob disease	0.00319	0.00479	CbGeAlD
Carfilzomib—PSMB2—Signaling by WNT in cancer—YWHAZ—Creutzfeldt-Jakob disease	0.00317	0.00946	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by WNT in cancer—YWHAZ—Creutzfeldt-Jakob disease	0.00317	0.00946	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by WNT in cancer—YWHAZ—Creutzfeldt-Jakob disease	0.00317	0.00946	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by WNT in cancer—YWHAZ—Creutzfeldt-Jakob disease	0.00313	0.00933	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism of RNA—YWHAZ—Creutzfeldt-Jakob disease	0.00301	0.00898	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism of RNA—YWHAZ—Creutzfeldt-Jakob disease	0.00301	0.00898	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism of RNA—YWHAZ—Creutzfeldt-Jakob disease	0.00301	0.00898	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism of RNA—YWHAZ—Creutzfeldt-Jakob disease	0.00297	0.00885	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.00285	0.0085	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.00263	0.00786	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by Wnt—YWHAZ—Creutzfeldt-Jakob disease	0.00261	0.0078	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by Wnt—YWHAZ—Creutzfeldt-Jakob disease	0.00261	0.0078	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by Wnt—YWHAZ—Creutzfeldt-Jakob disease	0.00261	0.0078	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by Wnt—YWHAZ—Creutzfeldt-Jakob disease	0.00258	0.00769	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00252	0.00753	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00251	0.00749	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.00246	0.00733	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.00246	0.00733	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.00246	0.00733	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.00242	0.00723	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00231	0.0069	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.0023	0.00686	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00205	0.00612	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00204	0.00609	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00197	0.00587	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00196	0.00584	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00191	0.00571	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00191	0.00571	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00191	0.00571	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00189	0.00563	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00175	0.00523	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00175	0.00523	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00175	0.00523	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00173	0.00515	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00155	0.00464	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00155	0.00464	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00155	0.00464	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00153	0.00457	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00149	0.00445	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00149	0.00445	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00149	0.00445	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00147	0.00439	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.0014	0.00418	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00139	0.00416	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00124	0.00371	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00124	0.0037	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.00124	0.00369	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.00123	0.00368	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.00115	0.00343	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.00114	0.00341	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00106	0.00317	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00106	0.00317	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00106	0.00317	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00105	0.00312	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00102	0.00304	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000943	0.00281	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000943	0.00281	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000943	0.00281	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.000938	0.0028	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.000938	0.0028	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.000938	0.0028	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00093	0.00277	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.000924	0.00276	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000871	0.0026	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000871	0.0026	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000871	0.0026	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000858	0.00256	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000804	0.0024	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000801	0.00239	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00061	0.00182	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00061	0.00182	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00061	0.00182	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000601	0.00179	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000563	0.00168	CbGpPWpGaD
